{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 444450342
| IUPAC_name = 4-chloro-''N''<sup>1</sup>-methyl-''N''<sup>1</sup>-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide
| image = Mefruside.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|mefruside}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 7195-27-9
| ATC_prefix = C03
| ATC_suffix = BA05
| ATC_supplemental =  
| PubChem = 4047
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = X1NS9SNS92
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01877
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 3907

<!--Chemical data-->
| chemical_formula =  
| C=13 | H=19 | Cl=1 | N=2 | O=5 | S=2 
| molecular_weight = 382.88 g/mol
| smiles = CC1(CCCO1)CN(C)S(=O)(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C13H19ClN2O5S2/c1-13(6-3-7-21-13)9-16(2)23(19,20)10-4-5-11(14)12(8-10)22(15,17)18/h4-5,8H,3,6-7,9H2,1-2H3,(H2,15,17,18)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = SMNOERSLNYGGOU-UHFFFAOYSA-N
}}

'''Mefruside''' ([[International Nonproprietary Name|INN]]) is a [[diuretic]] indicated for the treatment of edema and hypertension.<ref name="pmid4779251">{{cite journal |vauthors=Allen HB, Lee DA |title=A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension |journal=Curr Med Res Opin |volume=1 |issue=9 |pages=547â€“53 |year=1973 |pmid=4779251 |doi= 10.1185/03007997309111720|url=}}</ref>

It was developed by [[Bayer|Bayer A.G.]] and is sold under the tradename '''Baycaron'''.

==References==
{{Reflist}}

{{Diuretics}}

[[Category:Diuretics]]
[[Category:Sulfonamides]]
[[Category:Tetrahydrofurans]]
[[Category:Chloroarenes]]
[[Category:Carbonic anhydrase inhibitors]]


{{cardiovascular-drug-stub}}